Klaus Kuhlbusch

Title: Klaus Kuhlbusch: Innovator in Influenza Prevention

Introduction

Klaus Kuhlbusch is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the prevention of influenza virus transmission. With a total of 2 patents, Kuhlbusch's work is aimed at reducing the risk of influenza epidemics and pandemics.

Latest Patents

Kuhlbusch's latest patents focus on a compound and method for preventing the transmission of the influenza virus. The invention involves administering an effective amount of a specific compound to patients infected with the influenza virus, referred to as 'index patients'. The compound is designed to reduce the infectivity of the influenza virus, thereby minimizing the risk of triggering an epidemic or pandemic. The method requires that the compound be administered to at least 10% of all influenza-infected individuals within a city's or country's population.

Career Highlights

Throughout his career, Klaus Kuhlbusch has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and Shionogi Company Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions for public health challenges.

Collaborations

Kuhlbusch has collaborated with esteemed colleagues in his field, including Takeshi Noshi and Takahiro Noda. These partnerships have likely enhanced his research and development efforts in combating influenza.

Conclusion

Klaus Kuhlbusch is a dedicated inventor whose work in influenza prevention is vital for public health. His innovative methods and compounds have the potential to significantly impact the management of influenza outbreaks.